Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 711-testes-procedures-with-cc-mcc
    Ask Trek AI about this page

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    DRG 711 encompasses inpatient hospital stays for testes procedures accompanied by a Major Complication or Comorbidity or Complication or Comorbidity, covering surgical management of testicular conditions with added clinical complexity. It matters for inpatient reimbursement because the presence of these additional diagnoses increases resource intensity and influences Medicare payment assignment under the Diagnosis-Related Group system.

    Customize your policy alerts

    Sign up for drg 711 policy alerts

    Get alerted when payer policies referencing 711 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 711 Overview

    DRG 711 covers hospital admissions for testes procedures when a Major Complication or Comorbidity or Complication or Comorbidity is present, including surgical interventions for testicular conditions complicated by additional diagnoses. This Diagnosis-Related Group groups cases with higher resource use than uncomplicated procedures, affecting Medicare inpatient reimbursement by increasing relative payment weights. It is relevant for urology and surgical teams managing complex testicular operations and for hospital billing and case-mix considerations. Understanding classification into this Diagnosis-Related Group affects payment assignment and documentation priorities.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute surgical technique and perioperative management trials: randomized or prospective comparative studies evaluating different surgical approaches (open, minimally invasive, or organ-sparing procedures) and perioperative protocols for patients undergoing inpatient testes procedures complicated by comorbid conditions (the CC/MCC population may include patients with significant infection, bleeding, or systemic disease). These studies focus on intraoperative blood loss, operative time, complication rates, and short-term recovery metrics in higher-risk inpatients; findings inform surgeons and hospital administrators about best practices for reducing immediate morbidity and length of stay. Results are relevant to payers and case managers because improved perioperative pathways can decrease resource utilization, readmissions, and reimbursements tied to complications within this DRG.
    • Comparative effectiveness and risk-stratification studies for management strategies in complicated testicular disease: observational cohorts or randomized trials comparing medical versus surgical management, timing of intervention, or adjunctive therapies (for example, antibiotic regimens in severe epididymo-orchitis with systemic illness or anticoagulation strategies in patients with bleeding risk). These trials enroll patients with CC/MCC-level comorbidities to identify which approaches yield lower complication rates, lower ICU utilization, and better functional outcomes. Such evidence helps clinicians tailor care for sicker inpatients and assists payers in understanding which strategies are cost-effective and reduce high-cost events within this DRG.
    • Post-discharge outcomes and health services research: prospective follow-up studies and registry-based analyses tracking readmissions, long-term complications (fertility, chronic pain, prosthesis issues), functional recovery, and patient-reported outcomes after hospital discharge in patients treated under Testes Procedures with CC/MCC. This research often targets transitions of care, adherence to follow-up, and rehabilitation needs in a population with complex medical backgrounds to identify predictors of readmission and late complications. Findings guide discharge planning, outpatient resource allocation, and payer policies aimed at reducing preventable downstream costs associated with this DRG.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.